Literature DB >> 29670308

The cost of asthma medicines.

Helen K Reddel1, Kirsty Lembke2, Nicholas J Zwar3.   

Abstract

Keywords:  asthma; cost of drugs; medication adherence

Year:  2018        PMID： 29670308      PMCID： PMC5895474          DOI： 10.18773/austprescr.2018.011

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  9 in total

Review 1.  Encouraging adherence to long-term medication.

Authors:  Tim Usherwood
Journal:  Aust Prescr       Date:  2017-08-01

2.  Low-dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  S Suissa; P Ernst; S Benayoun; M Baltzan; B Cai
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

3.  Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia.

Authors:  Helen K Reddel; Lutz Beckert; Angela Moran; Tristram Ingham; Rosario D Ampon; Matthew J Peters; Susan M Sawyer
Journal:  Respirology       Date:  2017-08-09       Impact factor: 6.424

4.  Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study.

Authors:  Helen K Reddel; William W Busse; Søren Pedersen; Wan C Tan; Yu-Zhi Chen; Carin Jorup; Dan Lythgoe; Paul M O'Byrne
Journal:  Lancet       Date:  2016-11-30       Impact factor: 79.321

5.  Shared treatment decision making improves adherence and outcomes in poorly controlled asthma.

Authors:  Sandra R Wilson; Peg Strub; A Sonia Buist; Sarah B Knowles; Philip W Lavori; Jodi Lapidus; William M Vollmer
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

6.  Treatment patterns in the months prior to and after asthma-related emergency department visit.

Authors:  David A Stempel; Craig S Roberts; Richard H Stanford
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

7.  Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease.

Authors:  Rosario D Ampon; Helen K Reddel; Patricia K Correll; Leanne M Poulos; Guy B Marks
Journal:  Med J Aust       Date:  2009-09-21       Impact factor: 7.738

8.  Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Authors:  David A Stempel; Ibrahim H Raphiou; Kenneth M Kral; Anne M Yeakey; Amanda H Emmett; Charlene M Prazma; Kathleen S Buaron; Steven J Pascoe
Journal:  N Engl J Med       Date:  2016-03-06       Impact factor: 91.245

9.  Effect of Financial Stress and Positive Financial Behaviors on Cost-Related Nonadherence to Health Regimens Among Adults in a Community-Based Setting.

Authors:  Minal R Patel; Daniel J Kruger; Suzanne Cupal; Marc A Zimmerman
Journal:  Prev Chronic Dis       Date:  2016-04-07       Impact factor: 2.830
  9 in total
  3 in total

Review 1.  Managing the overlap of asthma and chronic obstructive pulmonary disease.

Authors:  Anne Knight
Journal:  Aust Prescr       Date:  2020-02-03

Review 2.  Updated Australian guidelines for mild asthma: what's changed and why?

Authors:  Helen K Reddel
Journal:  Aust Prescr       Date:  2020-12-01

3.  A Targeted Approach to Improve Asthma Control Using Community Pharmacists.

Authors:  Sarah Serhal; Bandana Saini; Sinthia Bosnic-Anticevich; Ines Krass; Lynne Emmerton; Bonnie Bereznicki; Luke Bereznicki; Bernadette Mitchell; Frances Wilson; Bronwen Wright; Kiara Wilson; Naomi Weier; Rebecca Segrott; Rhonda Cleveland; Stephen Jan; Sana Shan; Laurent Billot; Carol Armour
Journal:  Front Pharmacol       Date:  2021-12-27       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.